TGFB1 and metabolic dysfunction-associated steatohepatitis: IFN-γ deficiency in mice advances the development of nonalcoholic steatohepatitis (NASH) in a transforming growth factor-β (TGF-β) and IL-13 signaling-dependent manner [58].